Morvarid Kabir

4PUBLICATIONS
6CO-AUTHORS
Veterinary pharmacologyMetabolic medicinePlasma physics; fusion plasmas; electrical dischargesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 24, 2023
Dapagliflozin prevents abdominal visceral and subcutaneous adipose tissue dysfunction in the insulin-resistant canine model.

Morvarid Kabir, Richard N Bergman, Jay Porter

|Feb 15, 2022
The Physiology of Insulin Clearance.

Richard N Bergman, Morvarid Kabir, Marilyn Ader

|Apr 30, 2021
Correction: Paszkiewicz et al. A Peripheral CB1R Antagonist Increases Lipolysis, Oxygen Consumption Rate, and Markers of Beiging in 3T3-L1 Adipocytes Similar to RIM, Suggesting That Central Effects Can Be Avoided. Int. J. Mol. Sci. 2020, 21, 6639.

Rebecca L Paszkiewicz, Richard N Bergman, Roberta S Santos

|Sep 15, 2020
A Peripheral CB1R Antagonist Increases Lipolysis, Oxygen Consumption Rate, and Markers of Beiging in 3T3-L1 Adipocytes Similar to RIM, Suggesting that Central Effects Can Be Avoided.

Rebecca L Paszkiewicz, Richard N Bergman, Roberta S Santos

Pageof 1

Frequent Collaborators

2 joint publications

Roberta S Santos

2 joint publications

Richard N Bergman

1 joint publications

Orison O Woolcott

1 joint publications

Malini S Iyer